Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

On CNBC's "Mad Money Lightning Round," Jim Cramer praised home improvement retailer Lowe's Companies and CrowdStrike Holdings ...

UT Dell Medical School study helps solve question of when to start blood thinners after a stroke in someone with AFib.

AstraZeneca’s top medical executive Cristian Massacesi will replace Bristol Myers’ current chief medical officer, Samit ...

Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part ...

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer reflected on. When asked about the stock during the ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit managers.

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the largest and most well-known American pharmaceutical companies.

Pharmaceutical companies have been in talks with the U.S. government to figure out how to bring drug prices down after President Trump signed in May an executive order that ties U.S. prices to the ...